State Pension worries? I’d invest £400 a month in UK shares to retire rich

Rupert Hargreaves explains how investors can build a large financial nest-egg and beat the State Pension by using a basket of UK shares.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

According to several surveys, many potential retirees are worried about their State Pensions in retirement.

If you fall into this bracket, today I’m going to explain how you could revolutionise your financial prospects with UK shares and an investment of just £400 a month.

Time to beat the State Pension

If you have State Pension worries, the best way to get around any potential cash crunch in later life is to set up a private pension.

You don’t need to have a tremendous amount of money to do this. Most online stockbrokers allow investors to set up their own SIPP, which is an extremely tax-efficient way of saving for the future.

Indeed, any money contributed to a SIPP is entitled to tax relief at your marginal tax rate. That is 20% for basic rate taxpayers. This means for every £80 you contribute, the government will add another £20, taking the total up to £100.

On top of this, any income or capital gains earned on the money invested inside one of these tax-efficient wrappers is tax-free. These key benefits are what makes SIPPs perfect for investors trying to beat the State Pension. 

Investors can own a whole range of assets and investments inside a SIPP. Most online stockbrokers will also let you set up a regular investment plan. These plans allow investors to put away as little as £50 a month (or £62.50 after basic rate tax relief).

Fifty pounds a month might not seem like much at first. However, thanks to the power of compound interest, a small investment like that could grow into a large fortune.

Picking investments

I think buying a basket of UK shares may be the best way to invest SIPP funds. High-quality blue-chip stocks such as Unilever and GlaxoSmithKline have an excellent track record of producing robust returns for investors. 

I think this is likely to continue. These companies’ competitive advantages should help them stay ahead of the competition for decades to come. As such, if you want to beat the State Pension, it could be worth taking a closer look at these companies. 

Over the past three-and-a-half decades, UK blue-chips have produced an average annual return of around 8%. At this rate of return, my figures show that it would be possible to turn an investment of just £400 a month, or £500 after SIPP tax relief, into a large financial nest-egg.

According to my calculations, £500 a month invested at a rate of return of 8% per annum would be worth £750,000 after 30 years. This would be enough to provide an income of £30,000 per annum in retirement. That is a considerable sum in comparison to the State Pension.

The current rate of State Pension is less than £10,000 a year.

So, that’s how I think just £400 a month invested in UK shares could you beat the State Pension. Over the long-term, thanks to the power of compound interest, this small monthly contribution could grow into a large financial nest-egg removing any worries you may have.

Rupert Hargreaves owns shares in Unilever. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »